Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)
Recent comments
3 days 18 hours ago
10 weeks 3 days ago
14 weeks 4 days ago
15 weeks 4 days ago
15 weeks 4 days ago
36 weeks 5 days ago
40 weeks 6 days ago
42 weeks 3 days ago
42 weeks 4 days ago
1 year 2 weeks ago